(550 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants - An EAACI Position PaperAbstract It is well-established that food proteins, such as egg, soya, cow’s milk a...
-
Food processing and occupational respiratory allergy- An EAACI position paperAbstract Occupational exposure to foods is responsible for up to 25% of cases of occupati...
-
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityAbstract Immediate and nonimmediate hypersensitivity reactions to iodinated contrast medi...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
Role of dietary fiber in promoting immune health - An EAACI position paperAbstract Microbial metabolism of specific dietary components, such as fiber, contributes ...
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paperAbstract Chronic airway diseases such as asthma and chronic obstructive pulmonary disease...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paperAbstract Because of the inflammatory mechanisms of most chronic upper airway diseases suc...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"Abstract Background: Although there is a considerable body of knowledge about allergen ...
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergyAbstract An accurate diagnosis of β-lactam (BL) allergy can reduce patient morbidity and...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2Abstract The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the se...
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children - EAACI position paperAbstract Gastro-oesophageal reflux (GOR) and food allergy (FA) are common conditions, esp...
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paperAbstract A recent survey of the European Academy of Allergy and Clinical Immunology (EAAC...
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paperAbstract Allergy and respiratory disorders are common in young athletic individuals. In t...
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAbstract The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pande...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentAbstract Insect venom allergy is the most frequent cause of anaphylaxis in Europe and poss...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest GroupAbstract Women’s work has traditionally been considered less hazardous to health in...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position PaperAbstract Background: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensusAbstract Background: Although there are many asymptomatic patients, one of the problems ...
-
The development of birch pollen seasons over 30 years in Munich, Germany - An EAACI task force reportThe global warming–oriented climate change is able to induce changes in the presentation...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) - a EAACI position paperAbstract NSAID-exacerbated respiratory disease (N-ERD) is a chronic eosinophilic, inflamm...
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria TaskforceAbstract Background: Although well described in adults, there are scarce and heterogene...
-
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disordersREAD HERE
-
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statementAbstract The vision of European Academy of Allergy and Clinical Immunology (EAACI) and th...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives - A report of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract With the worldwide spread of the novel severe acute respiratory syndrome coronav...
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paperAbstract Diagnostic allergens are defined as medicinal products in the EU. Marketing auth...
-
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force ReportAbstract Biomarkers for the diagnosis, treatment and follow-up of patients with rhinitis a...
-
The urgent need for a harmonized severity scoring system for acute allergic reactionsAbstract The accurate assessment and communication of the severity of acute allergic reac...
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthmaAbstract To fully understand the role of diet diversity on allergy outcomes and to set st...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paperAbstract The high prevalence of allergic diseases warrants for sufficient health care pro...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist in articles published in EAACI Journals: A bibliographic studyAbstract Research data derived from observational studies are accumulating quickly in the...
-
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer - a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract Elevated serum IgE levels are associated with allergic disorders, parasitosis an...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescentsAbstract Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatri...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paperAbstract Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by a n...
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)Abstract Therapeutic advances using targeted biologicals and small-molecule drugs have ac...
-
Influenza burden, prevention, and treatment in asthma - A scoping review by the EAACI Influenza in asthma task forceAbstract To address uncertainties in the prevention and management of influenza in people...
-
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - An EAACI Task Force ReportAbstract Background: The effectiveness of allergen immunotherapy (AIT) in seasonal and ...
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)An ARIA-EAACI statement has been devised to make recommendations on asthma, and not necess...
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European surveyAbstract Background: The European Academy of Allergy and Clinical Immunology has develo...
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperAbstract Background: Chronic rhinosinusitis is regarded as a chronic airway disease. Acc...
Show more Position Papers (79)Show Less-
-
Microbiota in immune-based therapies
-
Differential diagnosis
-
Autoimmunity in atopic diseases
-
Epithelial cell barrier and allergic diseases
-
An update on prevention of allergic diseases
-
Gut microbiome - based therapeutic approaches
-
Role Viral reactivations
-
Impaired olfaction: diagnostics and its role in diseases
-
Viral infection and asthma
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Novel insight into development of allergic diseases
-
Inflammatory biomarkers
-
Immunological basis of food aversion
-
Bronchial allergen challenge in research
-
Difficult to control asthma in children
-
Food industry perspective
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Electronic Health in Severe Asthma
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Linking bovine milk components and their possible association with allergic diseases
-
Immunotherapy in severe asthma (AIT)
-
New insights in urticaria mechanisms
-
Potential biomarkers for diagnosis and treatment for CSU
-
AI models
-
Elderly asthma
-
Launch of the Biological guidelines
-
Virtual care, social media and mHealth for allergy management
-
Novel pharamacological targets
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Environmental epigenomics of allergy
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
Probiotics and prebiotics: an on-going journey
-
Recognizing immediate reactions in contact dermatitis
-
Difficult to control asthma in adults
-
EAACI Guidelines on environmental health
-
Allergy to Kale
-
Food elimination diet in eosinophilic esophagitis and other eosinophilic gastrointestinal disorders (Clinical cases)
-
Tackling anaphylaxis
-
Hologenome and obesity
-
Bronchiectasis and severe asthma
-
Do adrenaline auto-injectors save lives?
-
Oral food challenges thresholds for clinical reactions
-
Alternative free-from foods to reach a balanced diet
-
Eosinophilic fasciitis, an unusual presentation
-
Update on drug allergy
-
Asma e alergia em Angola
-
Skin care from birth for allergy prevention: results today
-
It looks like urticaria – but is it?
-
Bronchial allergen challenge in the clinic
-
Over-the-counter allergy prevention weaning products
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
How do allergens sensitize?
-
Big data and cluster analysis: a real life perspective
-
Immune modulation in local allergic rhinitis
-
Neuroimmunology and allergy
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Focus on Patient. Personalised therapy for severe asthma
-
Asma e alergia em pandemia
-
Air pollution and allergy: call for action!
-
Global impact of the COVID-19 on the environment
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Novel therapeutic approaches targeting endotypes of severe airway disease
-
Airborne enzymes – New and re-emerging occupational hazards
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
A system biology and machine learning approach to childhood asthma
-
2'FL and LNnT shape the gut microbiome and metabolome in CMPA
-
Late onset T2 asthma – a case study
-
Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents
-
Insight from translational research on oral tolerance induction through breast milk
-
Targeted approaches for asthma
-
Impact of climate change on asthma exacerbations
-
Living with food allergy
-
The dilemma of food allergy additives
-
Early biomarkers for severe drug hypersensitivity reactions
-
How to improve outcomes
-
When hives are not chronic urticaria
-
Unusual presentations of contact dermatitis
-
How to keep a child with anaphylaxis safe in school
-
Can group consultations work in allergy? Learning from rheumatology
-
BAT in clinical practice. Is it possible?
-
Precision Medicine and AIT
-
Primary care in CRDs during COVID
-
Evidence of immunotherapy on allergy prevention?
-
Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis
-
Non-T2 directed biologicals
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
B cells in in chronic rhinosinusitis: friend or foe
-
Is anaphylaxis really rare in children?
-
Novel cell based assays in allergy diagnostics
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
The clinical clues and pitfalls in contact dermatitis
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
What do we learn from subgroup analyses in phase-III trials?
-
Updates in [severe] asthma in adults
-
Elevated tryptase – Now what?
-
Impacting quality of life with PALFORZIA
-
